New York, Jan 25, 2026, 13:57 (EST) — Market closed.
- Shares of Thermo Fisher slipped 2.11% to end Friday at $625.98.
- Results from the company are expected before the market opens on Jan. 29.
- Traders are gearing up for the Fed’s Jan. 27-28 meeting as well as Danaher’s earnings report due Jan. 28.
Shares of Thermo Fisher Scientific Inc dropped 2.11% Friday to $625.98, breaking a three-day rally as U.S. markets showed mixed results heading into the weekend. The stock closed roughly 2.8% shy of its 52-week high of $643.99, which was reached just the day before, on volume that surpassed recent averages.
With U.S. markets closed on Sunday, Thermo Fisher’s recent dip leaves investors eyeing a busy week that could reshape the stock’s short-term outlook. The company plans to report its fourth-quarter and full-year 2025 earnings before the open on Thursday, Jan. 29, followed by a conference call at 8:30 a.m. ET.
The backdrop is restless. After early-year geopolitical shocks, investors might refocus on earnings and interest rate trends, Reuters reported. PNC’s chief investment strategist Yung-Yu Ma called the past few days a “short but steep roller-coaster ride.” Franklin Templeton strategist Chris Galipeau was more direct: “earnings are the driver.” Reuters
Thermo Fisher wasn’t alone on Friday. Agilent Technologies dropped 2.58%, and Danaher was down 2.11%. It’s a sign that life-science tools stocks tend to move in tandem when there’s uncertainty around customer spending and upcoming guidance.
The S&P 500 health care index dropped 0.56% on Friday, lagging behind a mostly flat session in the broader market.
According to Thermo Fisher’s data, estimates have narrowed ahead of the earnings report. The Zacks consensus, sourced from Nasdaq, forecasts earnings per share of $6.44 on roughly $11.95 billion in revenue—rises of 5.6% and 4.9% compared to the same period last year.
Investors will get two key events before Thermo Fisher’s report that could shift sentiment in the sector. Danaher will webcast its quarterly earnings call on Wednesday, Jan. 28 at 8:00 a.m. ET. At the same time, the Federal Reserve holds its policy meeting from Jan. 27-28.
The setup works both ways. If Thermo Fisher’s guidance turns cautious around customer budgets or order trends, the stock could fall sharply, especially as markets remain sensitive to macro headlines.
Thursday’s report and call are next on the docket. Traders will zero in on management’s take on demand for lab products, instruments, and biopharma services — and see if it matches Danaher’s commentary from the day before.
